Summary
The cytoplasmic concentrations of ER, AR, PR, and GR were determined in 124 specimens of normal and abnormal endometrium and other uterine human tissues by the DCC technique. In the endometrial carcinoma group, we observed that pretreatment with MAP leads to low cellularity, higher amount of AR, lower amounts of detectable ER, GR, and PR: the last receptor was almost always absent. A positive correlation between ER presence and tumor grade of differentiation was found in endometrial tumors from hormoneuntreated patients. With the value of 142 fmol/mg DNA as the cut off point between high and low binding capacity, the frequency of the single receptors within the hormone-untreated cancer group ranged from 61% to 88%; ER and PR were simultaneously present in 55% of cases (they are tightly correlated in the different biopsies with respect to frequency and amount); ER-AR-PR were present in 45% and all the four receptors in 40% of cases. Slightly higher values were found in normal endometrium collected from hormone-untreated patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- ER:
-
17β-estradiol receptor
- AR:
-
5α-dihydrotestosterone receptor
- PR:
-
progesterone receptor
- GR:
-
glucocorticoid receptors
- α-DHT:
-
5α-dihydrotestosterone
- β-DHT:
-
5β-dihydrotestosterone
- MAP:
-
medroxyprogesterone acetate
- P:
-
progesterone
- F:
-
cortisol
- T:
-
testosterone
- E:
-
17β-estradiol
- DES:
-
diethylstilbestrol
- TEBG:
-
testosterone-estradiol binding globulin
- CBG:
-
corticosteroid binding globulin
- DCC:
-
dextran-coated charcoal
- R 1881:
-
methyltrienolone
- Kd:
-
dissociation constant
References
Bloom N, tobin E, Degenshein GA (1977) Clinical correlation of endocrine ablation with estrogen and progesterone receptors in advanced breast cancer. Progr Cancer Res Ther4:125–139
Bonte, J (1972) Medroxyprogesterone in the management of primary and recurrent or metastatic uterine adenocarcinoma. Acta Obstet Gynecol Scand 19:21–24
Chen PS, Mills IH, Bartter FC (1961) Ultrafiltration studies of steroid-protein binding. J Endocrinol 23:129–137
Crocker SG, Milton PJD, King RJB (1974) Uptake of [6,7-3H] 17β-oestradiol by normal and abnormal human endometrium. J Endocrinol 62:145–152
Daxenbichler G, Grill HJ, Wittliff JL, Dapunt O (1977) Comparison of specific estrogen and progesterone binding proteins in human myometrium and leiomyomas. Acta Endocrinol 84:62–63
De Giovanni C, Bercovich E, Martelli A, Soli M, Nanni P, Grilli, S, Galli MC (1978) Steroid hormone binding proteins in normal and neoplastic human kidney. IRCS Med Sci 6, 419
Evans LH, Martin JD, Hähnel R (1973) Estrogen receptor concentration in normal and pathological human uterine tissues. J Clin Endocrinol Metab 38:23–32
Farber M, Conrad S, Heinrichs WL, Herrmann WL (1972) Estradiol binding by fibroids tumors and normal myometrium. Obstet Gynecol 40:479–486
Friberg LG, Kullander S, Persijn JP, Korsten CB (1978) On receptors for estrogens (E2) and androgens (DHT) in human endometrial carcinoma and ovarian tumours Acta Obstet Gynecol Scand 57: 261–264
Galli MC, Gola G, Orlandi C, Rocchetta R, Nanni P, Grilli, S, De Giovanni C (1978) Steroid hormone binding proteins in normal and neoplastic human ovary. IRCS Med Sci 6:418
Grilli, S, Ferreri AM, Gola G, Rocchetta R, Orlandi C, Prodi G (1977) Cytoplasmic receptors for 17β-estradiol, 5α-dihydrotestosterone, and progesterone in normal and abnormal human uterine tissues. Cancer Lett 2:247–258
Grilli, S, Galli MC, Nanni P, De Giovanni C, Prodi G (1978) Medroxyprogesterone acetate (MAP): a specific tracer in determining progesterone binding protein. IRCS Med Sci 6:420
Gustafsson JÅ, Einhorn N, Elfström G, Nordenskjöld B, Wrange O (1977) Progestin receptor in endometrial carcinoma. Progr. Cancer Res Ther 4:299–312
Haukkamaa M, Karjalainen O, Luukkainen T (1971) In vitro binding of progesterone by the human endometrium during the menstraual cycle and by hyperplastic, atrophic and carcinomatous endometrium. Am J Obstet Gynecol 111:205–210
Horwitz KB, McGuire WL, Pearson OH, Segaloff A (1975) Predictive response to endocrine therapy in human breast cancer: an hypothesis. Science 189:726–727
Horwitz KB, McGuire WL (1977) Estrogen and progesterone their relationship in hormone-dependent breast cancer. Progr Cancer Res Ther 4:103–124
Iacobelli S, Sica G, Ranelletti F, Barile G (1978) An assessment of the effects of steroid hormones and antiestrogens on short-term organ culture of human endometrial carcinoma. Eur J Cancer 14:931–938
Janne O, Kontula K, Kauppila A, Syrjala P, Vihko R (1977) Estrogen and progestin receptors in human breast and endometrial tumors. Scand J Clin Lab Invest 37:81
Leclercq G, Heuson JC, Deboel MC, Legros N, Longeval F, Mattheiem WH (1977) Estrogen and progesterone receptor in human breast cancer. Progr Cancer Res Ther 4:141–153
Lippman M, Bolan G, Huff K (1976a) The effect of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4602–4609
Lippman M, Bolan G, Huff K (1976b) The effect of androgens and antiandrogens on hormone-responsive human cancer in long-term tissue culture. Cancer Res 36:4610–4618
Martin PM, Rolland PH, Gammerre M, Serment H, Toga M (1979) Estradiol and progesterone receptor in normal and neoplastic endometrium correlations between receptors, histopathological examination, and clinical responses under progestin therapy. Int J Cancer 23:321–329
McGuire WL (1979) Hormones, receptors and breast cancer. Plenary Lecture at The First International Congress on Hormones and Cancer, Rome, October 3–6 1979. (To be published)
Nicoletti G, Prodi G, Galli MC, De Giovanni C, Grilli S, Nanni P (1980) The simultaneous occurrence of cytoplasmic receptors for various steroid hormones in female normal and pathological breast tissues. Steroid Biochem (submitted) J
Notides AC, Hamilton DE, Rudolph JH (1972) Estrogen binding proteins of the human uterus. Biochim Biophys Acta 271:214–224
Pichon MF, Milgrom E (1977) Characterization and assay of progesterone receptor in human mammary carcinoma. Cancer Res 37:464–471
Pollow K, Lübbert H, Boquoi E, Kreuzer E, Pollow D (1975) Characterization and comparison of receptor for 17β-estradiol and progesterone in human proliferative endometrium and endometrial carcinoma. Endocrinology 96:319–328
Pollow K, Boquoi E (1976) Effect of gestagen therapy upon estradiol- and progesterone receptor-level and 17β-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma. Z Krebsforsch 86: 231–242
Pollow K, Schmidt-Gollwitzer M, Nevinny-Stickel J (1977) Progesterone receptors in normal human endometrium, and endometrial carcinoma. Progr Cancer Res Ther 4:313–338
Prodi G, De Giovanni C, Galli MC, Gola G, Grilli S, Rocchetta R, Orlandi C (1979) 17β-Estradiol, 5a-dihydrotestosterone, progesterone, and cortisol receptor in normal and neoplastic human endometrium. Tumori 65:241–253
Ramanath Rao B, Wiest WG, Allen WM (1971) Progesterone receptor in human endometrium. Endocrinology 95:1275–1281
Ramanath Rao B, Meyer JS (1977) Estrogen and progestin receptor in normal and cancer tissue. Progr Cancer Res Ther 4:155–169
Reed MJ, Hutton JD, Baxendale PM, Goodall AB, Fern M, James VH, Jacobs HS, Fischer PR (1978) Plasma hormone levels and the conversion of androstenedione to oestrone in women with endometrial cancer. J Endocrinol 79:548–558
Rubin BL, Gusberg SB, Butterly J, Han TC, Maralit M (1972) A screening test for estrogen dependence of endometrial carcinoma. Am J Obstet Gynecol 114:660–669
Satyaswaroop PG, Fleming H, Bressler RS, Gurpida E (1978) Human endometrial cancer cell cultures for hormonal studies. Cancer Res 38:4367–4375
Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672
Terenius L, Lindell A, Persson BH (1971) Binding of estradiol-17β to human cancer tissue of the female genital tract. Cancer Res 31:1895–1898
Terenius L (1973) Estrogen and progesterone binders in human and rat mammary carcinoma. Eur J Cancer 9:291–294
Teulings FAG, van Gilse, HA (1977) Demonstration of glucocorticoid receptors in human mammary carcinomas. Hormone Res 8:107–116
Trams G, Engel B, Lehmann F, Maass H (1973) Specific binding of oestradiol in human uterine tissue. Acta Endocrinol 72:351–360
Verma U, Laumas KR (1973) In vitro binding of progesterone to receptors in the human endometrium and the myometrium. Biochim Biophys Acta 317:403–419
Young PCM, Cleary RE (1974) Characterization and properties of progesterone binding components in human endometrium. J Clin Endocrinol Metab 39:425–439
Young PCM, Erlich CE, Cleary RE (1976) Progesterone binding in human endometrial carcinomas. Am J Ostet Gynecol 125:353–360
Author information
Authors and Affiliations
Additional information
This work was supported by a grant from Ministero della Pubblica Istruzione, Rome and “Donazione Testoni”, Bologna, Italy
Rights and permissions
About this article
Cite this article
Prodi, G., Nicoletti, G., De Giovanni, C. et al. Multiple steroid hormone receptors in normal and abnormal human endometrium. J Cancer Res Clin Oncol 98, 173–183 (1980). https://doi.org/10.1007/BF00405961
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00405961